KemPharm Stock News

The stock price of KemPharm Inc (Nasdaq: KMPH) has increased by over 10% pre-market. This is why it happened.

KemPharm, Inc. (KMPH) CEO Travis Mickle on Q4 2020 Results - Earnings Call Transcript

Corporate and Regulatory Highlights:

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Thursday, March 11, 2021, 4:30 p.m. ET

CELEBRATION, Fla., March 04, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announc

KemPharma (KMPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r

What a day. We saw the morning start with a new iteration of the Reddit stocks rally, and the afternoon close with new fears about digital ad companies.

Ovid Therapeutics Inc. (NASDAQ: OVID), KemPharm Inc (NASDAQ: KMPH), Aquestive Therapeutics Inc (NASDAQ: AQST) and Sorrento Therapeutics, Inc. (NASDAQ: SRNE) were among the health care gainers in Wedne

KemPharm's prodrug development platform got a huge boost from the FDA's new drug application nod for an ADHD treatment. The post KMPH Stock: The Big News That Has KemPharm Soaring Today appeared first

The stock price of KemPharm (NASDAQ: KMPH) has increased by over 75% pre-market. This is why it happened.

The FDA has approved KemPharm Inc's (NASDAQ: KMPH) market application for Azstarys (formerly referred to as KP415), a once-daily product for the treatment of attention deficit hyperactivity disord

Conference Call and Live Audio Webcast Scheduled for Tomorrow, Wednesday, March 3, at 8:30 a.m. ET

The stock price of KemPharm, Inc. (NASDAQ: KMPH) is trading at over 18% pre-market. This is why it happened.

Investors need to pay close attention to KemPharm (KMPH) stock based on the movements in the options market lately.

Financial Restructuring and Nasdaq Re-Listing Process Completed